According to Precedence Research, the radiopharmaceuticals market size has been estimated at USD 7.51 billion in 2025 and is projected to reach approximately USD 14.44 billion by 2034, growing at a ...

The MHRA has approved trofolastat to identify how far high-risk prostate cancer has spread before treatment, to detect ...